World Health Organization Sounds Concern Over Severe Shortage of Obesity Jabs
Fewer than a tenth of patients who could benefit from weight-loss injections like Wegovy have access to them, states the WHO as it releases its initial advice on the medications.
Considering in excess of 1,000,000,000 individuals worldwide currently obese, it is advocating for broader and more equitable availability to these injectable treatments.
Based on estimates, over two billion are projected to be obese by 2030 without intervention.
"Our new guidance recognises that excess weight is a chronic disease that can be managed with thorough and ongoing care," stated the agency's head Tedros Adhanom Ghebreyesus.
High costs, insufficient output, and supply-chain constraints are major hurdles to widespread availability to the treatments that can assist patients in reducing considerable weight, says the agency.
Weight-Loss Drug Shortage
Even in the current most favorable case, the production of GLP-1 therapies might only reach approximately 100 million people – less than 10% of those who need them, as stated by the WHO.
The recommendation encourages countries and companies to widen access, via measures such as patent sharing.
Exclusive production rights on the active ingredient – the core component of a leading brand – is scheduled to end in multiple nations in 2026.
How Weight-Loss Drugs Work
The injections imitate a natural hormone to delay gastric emptying, suppress the appetite and enhance the sense of being full so individuals consume fewer calories.
Individuals typically see weight reduction in the initial weeks of starting on the regular doses.
Studies points to patients may regain a significant portion after a year of halting the treatment, when their typical appetite return.
To be above a healthy weight raises your likelihood for developing diseases, such as type 2 diabetes, cardiovascular issues, stroke, and some cancers.
Excess weight affects individuals in every country and was responsible for over three and a half million deaths worldwide in 2024, as per the WHO.
